Consultation and Peer Review

The contract titled "Consultation and Peer Review" issued by the Food and Drug Administration is a forecast opportunity related to professional services within the NAICS code 541690, which covers other scientific and technical consulting services. While specific details such as the solicitation number, place of performance, and contracting officer remain undetermined, the contract aims to secure expert consultation and peer review services that support the FDA’s regulatory and scientific activities. The forecast was posted on March 11, 2026, indicating future planned procurement in this specialized area. Key points include that the contract does not specify a set-aside type, suggesting it may be open to all qualified vendors. The primary contacts for the opportunity include a Program Point of Contact, reachable via a designated FDA acquisitions email, and a Contracting Officer whose identity and contact details are yet to be confirmed. Potential bidders are encouraged to monitor the provided online link for updates and further procurement information from the FDA’s Office of Small and Disadvantaged Business Utilization.